<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2025.605</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-2427</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>A neural network for predicting occurrence of uterine fibroids in women of reproductive age</article-title><trans-title-group xml:lang="ru"><trans-title>Прогнозирование возникновения миомы матки у женщин репродуктивного возраста с помощью нейронной сети</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5474-1080</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зиганшин</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ziganshin</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зиганшин Айдар Миндиярович, д.м.н., проф.</p><p>450008, Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Aidar M. Ziganshin, MD, Dr Sci Med, Prof. </p><p>3 Lenin Str., Ufa 450008</p></bio><email xlink:type="simple">Zigaidar@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9524-8962</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дикке</surname><given-names>Г. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dikke</surname><given-names>G. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дикке Галина Борисовна, д.м.н., проф.</p><p>190013 Санкт-Петербург, Московский проспект, д. 22, лит. М</p></bio><bio xml:lang="en"><p>Galina B. Dikke, MD, Dr Sci Med, Prof.</p><p>22 lit. М, Moskovskiy Prospekt, Saint Petersburg 190013</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3799-4080</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Янбарисова</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Yanbarisova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Янбарисова Алия Ринатовна</p><p>450008, Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Aliya R. Yanbarisova</p><p>3 Lenin Str., Ufa 450008</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Башкирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ЧОУ ДПО «Академия медицинского образования имени Ф.И. Иноземцева»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Inozemtsev Academy of Medical Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>05</month><year>2025</year></pub-date><volume>19</volume><issue>2</issue><fpage>180</fpage><lpage>191</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ziganshin A.M., Dikke G.B., Yanbarisova A.R., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Зиганшин А.М., Дикке Г.Б., Янбарисова А.Р.</copyright-holder><copyright-holder xml:lang="en">Ziganshin A.M., Dikke G.B., Yanbarisova A.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/2427">https://www.gynecology.su/jour/article/view/2427</self-uri><abstract><sec><title>Aim</title><p>Aim: to create a model for predicting emergence of uterine leiomyoma (UL) using neural network analysis of risk factors and to evaluate its prognostic characteristics.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. A retrospective case-control study with 209 patients aged 20–47 years was performed covering the years from 2022 to 2024. Two groups of patients were identified: 1 – 106 women with UL, 2 – 103 patients without UL. Preliminary data processing was carried out, followed by a quantitatively analyzed relationship between risk factors and UL development using neural network analysis. The multilayer perceptron method was used to create a prognostic model for predicting UL emergence.</p></sec><sec><title>Results</title><p>Results. During the study, there were selected 12 model-based factors showing statistically significant inter-group differences: body mass index (BMI), age at menarche, number of abortions and spontaneous abortions, age at first birth, presence of arterial hypertension (AH), benign ovarian tumors, history of in vitro fertilization, level of anti-Müllerian hormone, number of pregnancies, serum cholesterol and glucose levels. The prediction accuracy for the developed model was 92.3 %, sensitivity – 90.6 %, specificity – 94.2 %. The predictive value was confirmed using ROC analysis – the area under the curve was 0.93 (95 % confidence interval = 0.91–0.94; p &lt; 0.001), which proves the promise of this method for clinical practice. Modifiable and potentially modifiable factors included increased BMI, AH, benign ovarian tumors, cholesterol and glucose levels. Such factors are considered as most relevant, due to an opportunity to be directly or indirectly affected, which proves an importance for preventive approach to this disease.</p></sec><sec><title>Conclusion</title><p>Conclusion. The developed model is an effective tool for predicting UL emergence (accuracy 92.3%), the use of which in clinical practice will allow shifting from the established paradigm of radical treatment to a preventive approach.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель: создать модель прогноза возникновения лейомиомы матки (ЛМ) на основе анализа факторов риска с помощью нейронной сети и оценить ее прогностические характеристики.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В период с 2022 г. по 2024 г. выполнено ретроспективное исследование «случай–контроль» 209 пациенток в возрасте 20–47 лет, среди которых были выделены 2 группы: группа 1 – 106 женщин с ЛМ, группа 2 – 103 пациентки без ЛМ. Проведена предварительная обработка данных с последующим количественным анализом взаимосвязи факторов риска с развитием ЛМ с помощью нейросетевого анализа. Для создания прогностической модели возникновения ЛМ применялся метод многослойного перцептрона.</p></sec><sec><title>Результаты</title><p>Результаты. В ходе проведенного исследования программой было отобрано 12 факторов, имевших статистически значимые различия при сравнении 2 групп: индекс массы тела (ИМТ), возраст менархе, число абортов и самопроизвольных абортов, возраст первых родов, наличие артериальной гипертензии (АГ), доброкачественных образований яичников, экстракорпоральное оплодотворение в анамнезе, уровень антимюллерова гормона, количество беременностей, содержание холестерина и глюкозы в крови. Точность прогноза разработанной модели составила 92,3 %, чувствительность – 90,6 %, специфичность – 94,2 %. Прогностическая ценность подтверждена с помощью ROC-анализа – площадь под кривой составила 0,93 (95 % доверительный интервал = 0,91–0,94; р &lt; 0,001), что доказывает перспективность данного метода для клинической практики. В число модифицируемых и потенциально-модифицируемых факторов вошли повышенный ИМТ, наличие АГ, доброкачественные новообразования яичников, содержание холестерина и глюкозы. Эти факторы представляются наиболее актуальными ввиду возможности оказать на них прямое или непрямое воздействие, что доказывает значимость превентивного подхода к данному заболеванию.</p></sec><sec><title>Заключение</title><p>Заключение. Разработанная модель является эффективным инструментом прогноза возникновения ЛМ (точность 92,3 %), использование которой в клинической практике позволит изменить устоявшуюся парадигму радикального лечения на превентивный подход.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>миома матки</kwd><kwd>лейомиома</kwd><kwd>ЛМ</kwd><kwd>факторы риска</kwd><kwd>профилактика</kwd><kwd>нейросетевой анализ</kwd><kwd>нейронная сеть</kwd><kwd>многослойный перцептрон</kwd><kwd>прогнозирование риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>uterine myoma</kwd><kwd>leiomyoma</kwd><kwd>UL</kwd><kwd>risk factors</kwd><kwd>prevention</kwd><kwd>neural network analysis</kwd><kwd>neural network</kwd><kwd>multilayer perceptron</kwd><kwd>risk prediction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Саноев Б.А., Ниёзова Г.Ш., Хикматова Н.И. Макро- и микроскопические проявления лейомиомы матки. Новый день в медицине. 2020;30(2):526–8.</mixed-citation><mixed-citation xml:lang="en">Sanoev B.A., Niyozova G.Sh., Hikmatova N.I. Macro- and microscopic manifestations of uterine leiomyomas. [Makro- i mikroskopicheskie proyavleniya lejomiomy matki]. Novyj den' v medicine. 2020;30(2):526–8. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng L.-C., Li H.-Y., Gong Q.-Q. et al. Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Front Med. 2022;9:1003605. https://doi.org/10.3389/fmed.2022.1003605.</mixed-citation><mixed-citation xml:lang="en">Cheng L.-C., Li H.-Y., Gong Q.-Q. et al. Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Front Med. 2022;9:1003605. https://doi.org/10.3389/fmed.2022.1003605.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9. https://doi.org/10.1002/ijgo.13102.</mixed-citation><mixed-citation xml:lang="en">Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9. https://doi.org/10.1002/ijgo.13102.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Адамян Л.В., Сонова М.М., Арсланян К.Н., Логинова О.Н. Современные аспекты комплексного лечения миомы матки. Лечащий врач. 2019;(3):46–50.</mixed-citation><mixed-citation xml:lang="en">Adamyan L.V., Sonova M.M., Arslanyan K.N., Loginova O.N. Modern aspects of complex treatment of hysteromyoma. [Sovremennye aspekty kompleksnogo lecheniya miomy matki]. Lechashchij vrach. 2019;(3):46–50. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Navarro A., Bariani M.V., Yang Q., Al-Hendy A. Understanding the impact of uterine fibroids on human endometrium function. Front Cell Dev Biol. 2021;9:633180. https://doi.org/10.3389/fcell.2021.633180.</mixed-citation><mixed-citation xml:lang="en">Navarro A., Bariani M.V., Yang Q., Al-Hendy A. Understanding the impact of uterine fibroids on human endometrium function. Front Cell Dev Biol. 2021;9:633180. https://doi.org/10.3389/fcell.2021.633180.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Аганезова Н.В., Аганезов С.С., Шило М.М. Миома матки: современные практические аспекты заболевания. Проблемы репродукции. 2022;28(4):97–105. https://doi.org/10.17116/repro20222804197.</mixed-citation><mixed-citation xml:lang="en">Aganezova N.V., Aganezov S.S., Shilo M.M. Uterine fibroids: modern practical aspects of the disease. [Mioma matki: sovremennye prakticheskie aspekty zabolevaniya]. Problemy reprodukcii. 2022;28(4):97–105. (In Russ.). https://doi.org/10.17116/repro20222804197.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Краснопольская К.В., Коган И.Ю. Миома матки и бесплодие: стратегии преодоления: руководство для врачей. М.: ГЭОТАР-Медиа, 2021. 144 с.</mixed-citation><mixed-citation xml:lang="en">Krasnopolskaya K.V., Kogan I.Yu. Uterine fibroids and infertility: coping strategies: a guide for physicians. [Mioma matki i besplodie: strategii preodoleniya: rukovodstvo dlya vrachej]. Moscow: GEOTAR-Media, 2021. 144 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Don E.E., Mijatovic V., van Eekelen R., Huirne J.A.F. The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study. Reprod Biomed Online. 2022;45(5):970–8. https://doi.org/10.1016/j.rbmo.2022.05.025.</mixed-citation><mixed-citation xml:lang="en">Don E.E., Mijatovic V., van Eekelen R., Huirne J.A.F. The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study. Reprod Biomed Online. 2022;45(5):970–8. https://doi.org/10.1016/j.rbmo.2022.05.025.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta J.K., Sinha A.S., Lumsden M.A., Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;2014(12):CD005073. https://doi.org/10.1002/14651858.CD005073.pub4.</mixed-citation><mixed-citation xml:lang="en">Gupta J.K., Sinha A.S., Lumsden M.A., Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;2014(12):CD005073. https://doi.org/10.1002/14651858.CD005073.pub4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Стрижаков А.Н., Давыдов А.И., Пашков В.М., Лебедев В.А. Доброкачественные заболевания матки. М.: ГЭОТАР-Медиа, 2011. 288 с.</mixed-citation><mixed-citation xml:lang="en">Strizhakov A.N., Davydov A.I., Pashkov V.M., Lebedev V.A. Benign diseases of the uterus. [Dobrokachestvennye zabolevaniya matki]. Moscow: GEOTAR-Media, 2011. 288 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Штраус Дж.Ф., Барбьери Р.Л., Гарджуло А.Р. Репродуктивная эндокринология Йена и Джаффе. Физиология, патофизиология, клиника, диагностика и лечение. 8-е изд. М.: МИА, 2022. 1200 с.</mixed-citation><mixed-citation xml:lang="en">Strauss J.F., Barbieri R.L., Gargiulo A.R. Yen and Jaffe’s Rеproduсtive Еndocrinologу. 8th ed. [Reproduktivnaya endokrinologiya Jena i Dzhaffe. Fiziologiya, patofiziologiya, klinika, diagnostika i lechenie. 8-e izd]. Moscow: MIA, 2022. 1220 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sohn G.S., Cho S., Kim Y.M. et al.; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018;61(2):192–201. https://doi.org/10.5468/ogs.2018.61.2.192.</mixed-citation><mixed-citation xml:lang="en">Sohn G.S., Cho S., Kim Y.M. et al.; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018;61(2):192–201. https://doi.org/10.5468/ogs.2018.61.2.192.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д., Воробьев А.В. Новейшие исследования и клинические практики в области гинекологии и перинатологии. Акушерство, Гинекология и Репродукция. 2024;18(5):620–4. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.583.</mixed-citation><mixed-citation xml:lang="en">Makatsariya A.D., Vorobev A.V. Up-to-date research and clinical strategies in gynecology and perinatology. [Novejshie issledovaniya i klinicheskie praktiki v oblasti ginekologii i perinatologii]. Obstetrics, Gynecology and Reproduction. 2024;18(5):620–4. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn. rep.2024.583.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации – Миома матки – 2024-2025-2026 (25.09.2024). М.: Министерство здравоохранения Российской Федерации, 2024. 23 с. Режим доступа: http://disuria.ru/_ld/14/1468_kr24O34p1D39p0M.pdf. [Дата обращения: 03.12.2024].</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines – Uterine fibroids – 2024-2025-2026 (25.09.2024). [Klinicheskie rekomendacii – Mioma matki – 2024-2025-2026 (25.09.2024). Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2024. 23 p. (In Russ.). Available at: http://disuria.ru/_ld/14/1468_kr24O34p1D39p0M.pdf. [Accessed: 03.12.2024].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Srinivas T., Lulseged B., Attari M.M.A. et al. Patient characteristics associated with embolization versus hysterectomy for uterine fibroids: a systematic review and meta-analysis. J Am Coll Radiol. 2024;21(5):729–39. https://doi.org/10.1016/j.jacr.2023.12.018.</mixed-citation><mixed-citation xml:lang="en">Srinivas T., Lulseged B., Attari M.M.A. et al. Patient characteristics associated with embolization versus hysterectomy for uterine fibroids: a systematic review and meta-analysis. J Am Coll Radiol. 2024;21(5):729–39. https://doi.org/10.1016/j.jacr.2023.12.018.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Borah B.J., Yao X., Laughlin-Tommaso S.K. et al. Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database. Obstet Gynecol. 2017;130(5):1047–56. https://doi.org/10.1097/AOG.0000000000002331.</mixed-citation><mixed-citation xml:lang="en">Borah B.J., Yao X., Laughlin-Tommaso S.K. et al. Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database. Obstet Gynecol. 2017;130(5):1047–56. https://doi.org/10.1097/AOG.0000000000002331.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J., Fan X., Gao J. et al. Cost effectiveness analysis of total laparoscopic hysterectomy versus total abdominal hysterectomy for uterine fibroids in Western China: a societal perspective. BMC Health Serv Res. 2022;22(1):252. https://doi.org/10.1186/s12913-022-07644-9.</mixed-citation><mixed-citation xml:lang="en">Yang J., Fan X., Gao J. et al. Cost effectiveness analysis of total laparoscopic hysterectomy versus total abdominal hysterectomy for uterine fibroids in Western China: a societal perspective. BMC Health Serv Res. 2022;22(1):252. https://doi.org/10.1186/s12913-022-07644-9.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart E.A. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646–55. https://doi.org/10.1056/nejmcp1411029.</mixed-citation><mixed-citation xml:lang="en">Stewart E.A. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646–55. https://doi.org/10.1056/nejmcp1411029.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">MacEachern S.J., Forkert N.D. Machine learning for precision medicine. Genome. 2020;64(4):416–25. https://doi.org/10.1139/gen-2020-0131.</mixed-citation><mixed-citation xml:lang="en">MacEachern S.J., Forkert N.D. Machine learning for precision medicine. Genome. 2020;64(4):416–25. https://doi.org/10.1139/gen-2020-0131.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ratna M.B., Bhattacharya S., Abdulrahim B., McLernon D.J. A systematic review of the quality of clinical prediction models in in vitro fertilisation. Hum Reprod. 2020;35(1):100–16. https://doi.org/10.1093/humrep/dez258.</mixed-citation><mixed-citation xml:lang="en">Ratna M.B., Bhattacharya S., Abdulrahim B., McLernon D.J. A systematic review of the quality of clinical prediction models in in vitro fertilisation. Hum Reprod. 2020;35(1):100–16. https://doi.org/10.1093/humrep/dez258.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">El Sabeh M., Borahay M. A. The future of uterine fibroid management: a more preventive and personalized paradigm. Reprod Sci. 2021;28(11):3285–8. https://doi.org/10.1007/s43032-021-00618-y.</mixed-citation><mixed-citation xml:lang="en">El Sabeh M., Borahay M. A. The future of uterine fibroid management: a more preventive and personalized paradigm. Reprod Sci. 2021;28(11):3285–8. https://doi.org/10.1007/s43032-021-00618-y.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wise L.A., Laughlin-Tommaso S.K. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016;59(1):2–24. https://doi.org/10.1097/GRF.0000000000000164.</mixed-citation><mixed-citation xml:lang="en">Wise L.A., Laughlin-Tommaso S.K. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016;59(1):2–24. https://doi.org/10.1097/GRF.0000000000000164.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Harmon Q.E., Brasky T.M. Risk factors for uterine fibroids: time to build on what we have learned. Fertil Steril. 2020;114(4):755–6. https://doi.org/10.1016/j.fertnstert.2020.07.059.</mixed-citation><mixed-citation xml:lang="en">Harmon Q.E., Brasky T.M. Risk factors for uterine fibroids: time to build on what we have learned. Fertil Steril. 2020;114(4):755–6. https://doi.org/10.1016/j.fertnstert.2020.07.059.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bajwa J., Munir U., Nori A. et al. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc J. 2021;8(2):e188–e194. https://doi.org/10.7861/fhj.2021-0095.</mixed-citation><mixed-citation xml:lang="en">Bajwa J., Munir U., Nori A. et al. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc J. 2021;8(2):e188–e194. https://doi.org/10.7861/fhj.2021-0095.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Briganti G., Le Moine O. Artificial intelligence in medicine: today and tomorrow. Front Med. 2020;7:509744. https://doi.org/10.3389/fmed.2020.00027.</mixed-citation><mixed-citation xml:lang="en">Briganti G., Le Moine O. Artificial intelligence in medicine: today and tomorrow. Front Med. 2020;7:509744. https://doi.org/10.3389/fmed.2020.00027</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
